Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . October 25th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Adverse Drug Effects - Pegylated interferon may cause vision disorders in chronic hepatitis C patients
Bioreactors - Escherichia coli produces purified hepatitis C virus NS5A protein
Chronic Hepatitis C - Hepatitis C virus infection does not stimulate hepatic interferon production
Gastroenterology - Liver enzymes monitor post-surgical liver function in those with HCV antibody
Hepatitis B Virus Therapy - Small interfering RNA stifles the production of hepatitis B virus
Cancer Research - Study questions link between SV40 and pleural mesothelioma
Collaborations - Companies to develop of Genelabs' hepatitis C compounds
Dermatology - Research released on HPV infection treatment
Diagnostics - Study finds demand for effective prognosis spurs uptake of molecular diagnostics
Drug Delivery - Long-term use of hepatitis-B drug effective for advanced liver disease
Environmental Health - Effects of inorganic arsenic on hepatic gene expression determined
Finance - ProMune maker raises $25 million in private financing
Foodborne Pathogens - Pathogenic enteric viruses persist in marinated mussels despite acid conditions
HIV/AIDS - New book on medication adherence for AIDS patients offers solutions
HIV/AIDS Therapy - d4T treatment enhances mitochondrial oxidative stress
Hepatitis C Vaccine Adjuvant - Novel cytokines induce hepatitis C virus-specific cyotoxic T cells
Imaging - Research at Beth Israel Deaconess broadens application of multidetector CT
Immunology - The immunogenic domains of hepatitis C virus E2 bear distinct properties
Legal Issues - Study shows Mississippi failing to adequately inspect funeral homes
Liver Cancer - Liver cirrhosis prognosis determined after first hepatic encephalopathy episode
Liver Regeneration - Fluidized bed bioreactor has potential for extracorporeal liver supply
Liver Transplantation - Duct-to-duct biliary reconstruction has limited utility
Mergers & Acquisitions - Biotechnology companies mail definitive proxy for proposed merger
Oncology - E-cadherin loss heightens liver cancer progression in murine models
Oncology Research - Constant light exposure increases cancer incidence and decreases lifespan
Polymicrobial Sepsis - Effect of ascorbic acid on hepatic vasoregulatory gene expression determined
Product Licensing - License application submitted for HIV-1 and hepatitis C, B screening assay
Stem Cell Research - PECAM-1 is expressed on hematopoietic stem cells throughout ontogeny
Viral Genomics - The natural mutation F97L enhances hepatitis B virus capsid assembly
Viral Hepatitis - Group B virus B infections in tamarins model human hepatitis C virus infection
Virus Neutralization - Antiviral antibodies block hepatitis C virus-like particle binding
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
